Add BrightSurf on Google Email

Bacteria load their syringes

Researchers have discovered that bacteria use mobile components of the injectisome to search for and transport specific proteins to be injected into host cells. This mechanism allows for efficient and specific protein delivery, enabling potential applications in medicine and biotechnology.

SourceMax-Planck-Gesellschaft·JournalNature Microbiology·TypeExperimental study·DateJan 3, 2024

From infamy to ingenuity

Researchers have uncovered the intricate molecular mechanism used by parasitic phytoplasma bacteria to manipulate plants. The discovery sheds light on a peculiar phenomenon in nature, where plants exhibit 'zombie-like' effects due to bacterial infection.

SourceJohn Innes Centre·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 5, 2023

Researchers lift the veil on stubborn probiotic

NC State researchers discovered a new way to make the difficult-to-characterize gut bacterium Bifidobacterium more responsive to antibiotics. They also found tiny changes in different strains that reflect large differences in their characteristics, highlighting the need for individualized CRISPR-based genome engineering approaches.

SourceNorth Carolina State University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJul 18, 2022

Bacteria acquire resistance from competitors

Researchers have discovered that bacteria can inject toxic proteins into their competitors, causing cell lysis and death, and then acquire antibiotic resistance by incorporating the released genetic material. This ability allows bacteria to rapidly develop resistance to antibiotics, posing a significant threat to patients in hospitals.

SourceUniversity of Basel·JournalCell Reports·DateDec 27, 2017

Bacteria free themselves with molecular 'speargun'

Researchers discovered that the pathogen Francisella tularensis uses a nano-machine called type VI secretion system (T6SS) to disrupt digestive vesicles and escape into the cytosol, allowing it to rapidly replicate. This efficient defense mechanism is crucial for the bacterium's success in an infection.

SourceUniversity of Basel·JournalNature Communications·DateJun 16, 2017

Defining the link between anti-TNF therapies and increased tuberculosis

A study by Steffen Stenger and colleagues found that anti-TNF therapies, such as infliximab, decrease the immune system's ability to fight infections, including tuberculosis. The researchers identified a key immune cell subset, CD45RA+ effector memory CD8+ T cells, which plays a major role in targeting the bacterium that causes TB.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 20, 2009